News
Important Only
Other
Curevac Receives Additional Positive Validity Decision From European Patent Office In Ongoing Litigation Against Biontech SE
May 15 (Reuters) - CureVac NV 5CV.DE:EQS-NEWS: CUREVAC RECEIVES ADDITIONAL POSITIVE VALIDITY DECISION FROM EUROPEAN PATENT OFFICE IN ONGOING LITIGATION AGAINST BIONTECH SECUREVAC NV - EPO DISMISSES OPPOSITION BY BIONTECH AND PFIZER ON PATENT EP 4 023 755 B1Reuters
Thu, May 15
Other
Cava Group Q1 Revenue USD 331.826 Million Versus. IBES Estimate USD 326.9 Million
May 15 (Reuters) - Cava Group Inc CAVA.N:CAVA GROUP Q1 REVENUE USD 331.826 MILLION VERSUS. IBES ESTIMATE USD 326.9 MILLIONCAVA GROUP Q1 INCOME FROM OPERATIONS USD 15.71 MILLIONCAVA GROUP Q1 PRETAX PROFIT USD 20.354 MILLIONCAVA GROUP Q1 NET INCOME USD 25.707 MILLIONReuters
Thu, May 15
Other
Take-Two Interactive forecasts annual bookings below revised estimates
May 15 (Reuters) - Take-Two Interactive TTWO.O forecast fiscal 2026 bookings below revised Wall Street expectations on Thursday, signaling that a strong lineup of releases this year may not cushion a hit from the delay of its highly anticipated "Grand Theft Auto VI".The company expects booki...Reuters
Thu, May 15
Other
IQST - IQSTEL Reports $57.6M Q1 Revenue In First Nasdaq Shareholder Letter, Reaffirms Path To $1 Billion By 2027 As Global Tech Evolution Accelerates
May 15 (Reuters) - iQSTEL Inc IQST.O:IQST - IQSTEL REPORTS $57.6M Q1 REVENUE IN FIRST NASDAQ SHAREHOLDER LETTER, REAFFIRMS PATH TO $1 BILLION BY 2027 AS GLOBAL TECH EVOLUTION ACCELERATESReuters
Thu, May 15
Other
Rocket Pharmaceuticals Presents Preliminary Data From Phase 1 Clinical Trial of RP-A601 For PKP2 Arrhythmogenic Cardiomyopathy At 28th Annual Meeting Of The American Society Of Gene And Cell Therapy
May 15 (Reuters) - Rocket Pharmaceuticals Inc RCKT.O:ROCKET PHARMACEUTICALS PRESENTS PRELIMINARY DATA FROM PHASE 1 CLINICAL TRIAL OF RP-A601 FOR PKP2 ARRHYTHMOGENIC CARDIOMYOPATHY AT 28TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE AND CELL THERAPYReuters
Thu, May 15
Other
Sean 'Diddy' Combs' chief accuser challenged over abuse claims, 'Freak Offs'
Cassie Ventura eager for 'Freak Offs,' defense claimsVentura denies being willing participantCombs pleaded not guilty to sex traffickingBy Jack Queen and Jonathan Stempel NEW YORK, May 15 (Reuters) - Sean "Diddy" Combs' defense team sought to portray Casandra Ventura on Thursd...Reuters
Thu, May 15
Other
US Supreme Court revives lawsuit against cop in fatal Houston shooting
Ashtian Barnes, 24, was killed in 2016 Houston incidentMother sued cop over alleged constitutional violationLower court limited its review of officer's actionsBy Andrew ChungWASHINGTON, May 15 (Reuters) - The U.S. Supreme Court revived on Thursday a Texas woman's civil rights lawsuit against...Reuters
Thu, May 15
Other
Travere Therapeutics Announces FDA Acceptance Of SNDA For FILSPARI® (Sparsentan) In FSGS
May 15 (Reuters) - Travere Therapeutics Inc TVTX.O:TRAVERE THERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF SNDA FOR FILSPARI® (SPARSENTAN) IN FSGSTRAVERE THERAPEUTICS INC - PDUFA TARGET ACTION DATE SET FOR JANUARY 13, 2026TRAVERE THERAPEUTICS INC - FILSPARI COULD BE FIRST FDA-APPROVED TREATMENT FOR FSGSReuters
Thu, May 15
Other
Hormel Foods Announces Retirement Of Scott Aakre, Group Vice President And Chief Marketing Officer For Retail, Following A Distinguished 35-Year Career
May 15 (Reuters) - Hormel Foods Corp HRL.N:HORMEL FOODS ANNOUNCES RETIREMENT OF SCOTT AAKRE, GROUP VICE PRESIDENT AND CHIEF MARKETING OFFICER FOR RETAIL, FOLLOWING A DISTINGUISHED 35-YEAR CAREERReuters
Thu, May 15
Other
Applied Materials forecasts third-quarter revenue above estimates
May 15 (Reuters) - Applied Materials AMAT.O forecast third-quarter revenue above Wall Street estimate on Thursday, betting on steady demand for its chipmaking equipment.The company forecast third-quarter revenue of $7.2 billion, plus or minus $500 million, compared with analysts' average estimat...Reuters
Thu, May 15
